PT-141 Australia: Bremelanotide Research Peptide Guide | Quantum Labs
PT-141 (bremelanotide) research overview — melanocortin pathway, vs Melanotan-2, delivery routes, Australian research-supply framing, and quality standards.
What is PT-141?
PT-141 is the research code for bremelanotide, a synthetic cyclic peptide in the melanocortin family. It is derived from work on α-melanocyte-stimulating hormone (α-MSH) analogues and is studied for central melanocortin receptor activity — particularly MC3R and MC4R — rather than as a peripheral tanning agent.
Quantum Labs supplies PT-141 as lyophilised research material for Australian laboratory use. It is HPLC-verified to a ≥99% purity specification and framed strictly for research — not as a consumer sexual-health product and not as a substitute for any prescription medicine.
Melanocortin pathway research context
Melanocortin receptors (MC1R–MC5R) mediate diverse physiology across pigmentation, energy balance, and central signalling. PT-141 research literature emphasises central MC3R/MC4R interest in models of sexual-response signalling. That is a research endpoint description, not a marketing claim about human outcomes.
Related melanocortin-family material on this site includes notes on tanning analogues in our Melanotan research overview. Those compounds and PT-141 are chemically related by lineage but are not interchangeable research tools.
PT-141 vs Melanotan-2 (research distinction)
Melanotan-2 is a non-selective α-MSH analogue historically discussed for pigmentation research and broader melanocortin activity. PT-141 (bremelanotide) was developed with a different optimisation goal and is usually discussed in the literature for central pathway models rather than tanning endpoints. Using one compound’s forum lore to dose or interpret the other is poor experimental practice.
Delivery routes in published work
Research protocols have used subcutaneous and intranasal routes depending on model and formulation. Intranasal interest is part of the broader nasal spray peptides conversation, but route choice must follow the primary paper for your endpoint — not catalogue defaults.
Handling: reconstitute lyophilised powder with study-appropriate sterile vehicle, refrigerate working solutions, log batch IDs, and use reconstitution tools for concentration maths.
Australian regulatory framing
Bremelanotide exists as a prescription medicine in some overseas jurisdictions for specific indications. That does not make research-grade PT-141 a consumer product in Australia. Quantum Labs supplies PT-141 for laboratory and pre-clinical research only, without therapeutic claims. For classification context: peptide legality in Australia, peptide therapy vs research peptides, and the research peptides hub.
Quality and documentation
Melanocortin peptide work still needs clean material: HPLC ≥99%, identity confirmation, third-party testing, and batch COAs on request — see quality, HPLC testing & COAs.
Catalogue links
PT-141 for Australian research supply. Research-grade bremelanotide, HPLC-verified ≥99% purity. View PT-141 · Quality standards · Research peptides guide.
